Raloxifene, an oestrogen–receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats
- 20 December 2000
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 410 (1) , 101-104
- https://doi.org/10.1016/s0014-2999(00)00865-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Estrogen-mediated up-regulation of the Ca-dependent constitutive nitric oxide synthase in the rat aorta and heart.Life Sciences, 2000
- Interactions of pro-inflammatory and vasoactive mediators with nitric oxide in the regulation of rat vascular permeability during laparotomyEuropean Journal of Pharmacology, 2000
- Coronary and uterine vascular responses to raloxifene in the sheepAmerican Journal of Obstetrics and Gynecology, 2000
- Endogenous nitric oxide in the maintenance of rat microvascular integrity against widespread plasma leakage following abdominal laparotomyBritish Journal of Pharmacology, 1999
- 1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in VivoJournal of Biological Chemistry, 1997
- Gonadal hormone substitutes: Effects on the cardiovascular systemOsteoporosis International, 1997
- Constitutive nitric oxide modulates the injurious actions of vasopressin on rat intestinal microcirculation in acute endotoxaemiaEuropean Journal of Pharmacology, 1994
- Induction of calcium-dependent nitric oxide synthases by sex hormones.Proceedings of the National Academy of Sciences, 1994
- Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthasesFEBS Letters, 1991
- Stimulus for vasopressin release during elective intra-abdominal operationsBritish Journal of Surgery, 1985